Petros Pharmaceuticals, Inc. (PTPI) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US71678J1007

Price
0.00 USD
Market cap
127,116.78 USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Petros Pharmaceuticals, Inc. financials

Fiscal year2025
Operating income-4.64 m USD
EBIT1.91 m USD
Net income1.91 m USD
Diluted EPS – continuing operations-1.56 USD

Full history since 2018, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.